Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Drug Stops Dangerous Bleeding In Patients Taking Factor Xa Inhibitors
Drug Stops Dangerous Bleeding In Patients Taking Factor Xa Inhibitors
The experimental drug andexanet was associated with control of serious bleeding in patients taking a common class of anticoagulants known as Factor Xa inhibitors, according to interim clinical trial r...
U.S. health spending twice other countries' with worse results
U.S. health spending twice other countries' with worse results
(Reuters Health) - The U.
ACC: Waiting on the FDA's heart-helping verdict, J&J shares more positive CV data for Invokana
ACC: Waiting on the FDA's heart-helping verdict, J&J shares more positive CV data for Invokana
Johnson & Johnson's Invokana is waiting for a CV benefit indication from the FDA.
FDA sends Hikma back to the clinic with generic Advair
FDA sends Hikma back to the clinic with generic Advair
Three Advair challengers have now faced rejections from the FDA.
Sagent issues voluntary recall of injectable anti-inflammatory due to impurities
Sagent issues voluntary recall of injectable anti-inflammatory due to impurities
Sagent issued a voluntary recall of methylprednisolone sodium succinate for injection after finding impurities during routine quality testing.
Eisai Co., Ltd. and Merck Enter Global Strategic Oncology Collaboration for LENVIMA® (lenvatinib mesylate)
Eisai Co., Ltd. and Merck Enter Global Strategic Oncology Collaboration for LENVIMA® (lenvatinib mesylate)
TOKYO & KENILWORTH, N.
Newer gout drug poses risk to heart patients
Newer gout drug poses risk to heart patients
Gout sufferers with major pre-existing heart disease face a higher risk of death if they are treated with the drug febuxostat, a large long-term study has concludedThe risk of death from cardiovascula...
AstraZeneca sees pivotal lung cancer trial results later in 2018
AstraZeneca sees pivotal lung cancer trial results later in 2018
LONDON (Reuters) - AstraZeneca now expects a key lung cancer study of two immunotherapy drugs to produce overall survival results in the second half of 2018, rather than the first half.
FDA Approves Trogarzo
FDA Approves Trogarzo
March 7, 2018 -- Today, the U.
Endocrinology Drugs Market in-Depth Analysis including key players Novo Nordisk, Sanofi, Merck
Endocrinology Drugs Market in-Depth Analysis including key players Novo Nordisk, Sanofi, Merck
HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of Endocrinology Drugs market.
Sanofi may seek U.S. approval for Dengvaxia despite Philippines outrage
Sanofi may seek U.S. approval for Dengvaxia despite Philippines outrage
PARIS (Reuters) - Sanofi will decide shortly whether to seek regulatory approval for its dengue vaccine Dengvaxia in the United States and remains committed to the medicine despite a health sc...
Europe's medicines regulator calls for recall of Biogen, AbbVie multiple sclerosis drug
Europe's medicines regulator calls for recall of Biogen, AbbVie multiple sclerosis drug
(Reuters) - Europe’s medicines regulator recommended the immediate suspension and recall of Biogen Inc and AbbVie Inc’s multiple sclerosis drug Zinbryta, following 12 reports of inflammati...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand